Clinical Trials Browser

FED × Capecitabine × Gastrointestinal × Clear all

NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

Phase 4 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Phase 1 Terminated

Gastrointestinal

Liver Neoplasms